Announcing the Use of Objective ADHD Testing Technology for Diagnosis and Treatment Test -Aims to Give Providers Increased Clinical Confidence Through Objective Data

Hawley Campbell
Jul 19
2 min read

HC Mental Health & Wellness

Telepsych NP announces Use of Objective ADHD Testing Technology for Diagnosis and Treatment Test Aims to Give Providers Increased Clinical Confidence Through Objective Data West Palm Beach, FL July 19, 2025 – HC Mental Health & Wellness Telepsych NP today announces its adoption of Qbtech’s objective ADHD tests, providing clinicians with actionable data for unbiased decision- making and support. These tests, created by the global leader in ADHD testing Qbtech, are the first FDA-cleared solution to aid clinicians when diagnosing and treating ADHD in children, adolescents, and adults.

Free 15 Minute Consultations

Qbtech offers both in-clinic and telehealth testing capabilities, which are conducted with a healthcare provider. Using a medical device administered on a computer, the in-clinic assessment uses an infrared tracking camera and head sensor to measure core ADHD symptoms – activity, inattention, and impulsivity – through a 15-20-minute computer- based test. Results are instantly analyzed and presented in a report that compares a patient’s results with a group of people of the same age and sex at birth without ADHD.

“We are excited to onboard a revolutionary technology to help our clinicians better understand core ADHD symptoms” says Hawley Campbell APRN, PMHNP-BC, FNP-BC, FNP-C. “Tests from Qbtech provide an opportunity to improve our care model for patients struggling with ADHD by providing objective, tangible results for a more comprehensive ADHD evaluation and treatment management program.” The data can be utilized to enable clinicians to determine treatment effects more accurately and efficiently. This gives patients access to tailored treatment faster – an outcome that can increase the quality of life for patients.

“Qbtech prides itself on providing our clinicians with industry-leading technology to treat their patients,” said Tony Doyle, Commercial Director at Qbtech. “ADHD has a significant role in the current mental health crisis, and incorporating objective data into the standard treatment of care is critical for patients to be treated effectively and efficiently.” HC Mental Health & Wellness Telepsych NP joins the growing list of nearly 10,000 clinicians globally adopting objective measures to more accurately rule in or rule out ADHD for their patients. Qbtech has administered more than 1 million tests, 120,000 conducted via telehealth. The test will be offered at HC Mental Health & Wellness Telepsych NP starting July 17, 2025 and implemented for all patients struggling with ADHD.

Book An Appointment

For more information, visit www.qbtech.com. About Qbtech Founded in 2002, Qbtech is a privately owned Swedish company that has developed leading solutions and products for improving the diagnosis, treatment, and follow-up of patients living with ADHD. Qbtech has operations in 14 countries and has offices in Stockholm, Houston, and London. Qbtech is an award-winning company recognized for their innovation, most recently winning the 2022 HSJ Partnership Award for the ‘Best Mental Health Partnership with the NHS’. www.qbtech.com